Rho Executive and Leadership Team

September, 2026

Leadership Overview

Rho has 6 executives leading key functions including strategy, operations, finance, technology, medical oversight, and corporate leadership.

Committed to advancing global health outcomes, Rho delivers comprehensive clinical research services that accelerate the drug development process for pharmaceutical and biotechnology partners worldwide.

Leadership Roles at Rho

  • Chief Executive Officer - Lawrence Morentz
  • Chief Financial Officer - Michael Szarowicz
  • Chief Operating Officer - Alena Hammond
  • President - Deborah Johnson
  • Technology Chief of Staff - Biljana Djordjevic
  • Chief Medical Officer - Andrew Feigin
  • Lawrence Morentz - Chief Executive Officer

    Lawrence Morentz, the Chief Executive Officer at Rho, directs the overarching strategic vision and long-term growth trajectory of the organization. By aligning clinical research capabilities with evolving pharmaceutical industry demands, the Chief Executive Officer ensures the company maintains a competitive edge in drug development services. Lawrence Morentz oversees high-level interactions with the Board and key stakeholders to secure sustainable expansion across North American and international markets. This leadership role involves fostering a culture of scientific excellence and operational integrity. Through the implementation of rigorous quality standards, the Chief Executive Officer drives the delivery of complex clinical trials. By prioritizing innovation in research methodologies, the Chief Executive Officer strengthens the market position of the firm. Ultimately, the Chief Executive Officer secures the financial and operational health of the enterprise while guiding the organization toward future milestones in the global life sciences sector.

    Michael Szarowicz - Chief Financial Officer

    Michael Szarowicz, the Chief Financial Officer at Rho, governs the fiscal strategy and financial planning activities of the organization. By overseeing capital allocation and budgeting processes, the Chief Financial Officer ensures the company maintains the necessary resources to support large-scale clinical research initiatives. Michael Szarowicz manages financial reporting and risk assessment to provide transparency for the Board and external partners. This leadership role involves analyzing market trends to inform investment decisions in new research technologies and infrastructure. By optimizing the cost structure of clinical operations, the Chief Financial Officer improves overall profitability and long-term stability. The Chief Financial Officer works closely with the executive team to align financial goals with the broader mission of accelerating drug development. Through disciplined fiscal management, the Chief Financial Officer supports the expansion of service offerings. Ultimately, the Chief Financial Officer secures the financial foundation required for the continued success of the firm.

    Alena Hammond - Chief Operating Officer

    Alena Hammond, the Chief Operating Officer at Rho, manages the daily execution of clinical research projects and internal business processes. By optimizing resource allocation across diverse therapeutic areas, the Chief Operating Officer ensures that project timelines meet stringent regulatory requirements. Alena Hammond coordinates cross-functional teams to streamline the drug development lifecycle, enhancing efficiency for global clients. This leadership role involves monitoring operational performance metrics to identify areas for continuous improvement. By integrating advanced project management tools, the Chief Operating Officer maintains high standards of data accuracy and trial integrity. The Chief Operating Officer collaborates with other executive leaders to align operational capacity with business development goals. Through the management of complex logistics and site coordination, the Chief Operating Officer supports the successful completion of clinical trials. Ultimately, the Chief Operating Officer drives operational excellence to sustain the reputation of the firm as a premier research partner.

    Deborah Johnson - President

    Deborah Johnson, the President at Rho, leads the organizational culture and oversees the execution of corporate initiatives across all business units. By fostering collaboration between departments, the President ensures that the company maintains a unified approach to delivering high-quality clinical research services. Deborah Johnson drives the implementation of corporate policies that support employee development and operational efficiency. This leadership role involves representing the firm in industry forums and building relationships with key pharmaceutical partners. By monitoring the competitive landscape, the President identifies opportunities for market expansion and service diversification. The President works in tandem with the executive team to translate the long-term vision into actionable business plans. Through the management of internal communications and organizational change, the President maintains alignment with the core mission of the firm. Ultimately, the President secures the operational success and market reputation of the organization through dedicated leadership and strategic oversight.

    Biljana Djordjevic - Technology Chief of Staff

    Biljana Djordjevic, the Technology Chief of Staff at Rho, architects the digital infrastructure and technological strategy supporting clinical research operations. By implementing secure data management systems, the Technology Chief of Staff ensures compliance with global regulatory standards for electronic records. Biljana Djordjevic coordinates the integration of advanced analytics and software solutions to enhance the efficiency of the drug development process. This leadership role involves bridging the gap between technical teams and operational departments to ensure seamless technology adoption. By overseeing the deployment of innovative digital tools, the Technology Chief of Staff drives improvements in trial data collection and analysis. The Technology Chief of Staff collaborates with the executive team to align technical capabilities with the strategic objectives of the firm. Through the management of cybersecurity protocols and system scalability, the Technology Chief of Staff protects sensitive research data. Ultimately, the Technology Chief of Staff enables the organization to leverage technology for superior clinical outcomes.

    Andrew Feigin - Chief Medical Officer

    Andrew Feigin, the Chief Medical Officer at Rho, provides clinical leadership and scientific oversight for all drug development programs. By guiding the design and execution of complex clinical trials, the Chief Medical Officer ensures that research protocols meet the highest medical and ethical standards. Andrew Feigin advises internal teams and external clients on regulatory pathways and safety monitoring throughout the development lifecycle. This leadership role involves interpreting clinical data to inform strategic decisions regarding trial progression and therapeutic efficacy. By maintaining deep expertise in medical science, the Chief Medical Officer enhances the credibility of the research services provided by the firm. The Chief Medical Officer collaborates with the executive team to ensure that medical strategy aligns with the overall business mission. Through the oversight of medical writing and safety reporting, the Chief Medical Officer supports the successful delivery of clinical results. Ultimately, the Chief Medical Officer drives scientific rigor to advance patient health.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Rho Top Executives and Leadership Team

    Who leads Rho?
    Rho is led by Lawrence Morentz (Chief Executive Officer), along with executives such as Michael Szarowicz (Chief Financial Officer) and Alena Hammond (Chief Operating Officer).
    Who is part of Rho’s executive team?
    The executive team of Rho includes leaders such as Lawrence Morentz (Chief Executive Officer), Michael Szarowicz (Chief Financial Officer), Alena Hammond (Chief Operating Officer) and other senior executives.
    How many executives does Rho have?
    Rho has 6 executives leading key business areas.
    What roles are included in Rho’s leadership team?
    The leadership team of Rho includes roles such as Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, President, Technology Chief of Staff.